Ethyl 5,7-difluoro-1H-indole-2-carboxylate

We are Ethyl 5,7-difluoro-1H-indole-2-carboxylate CAS:220679-10-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl 5,7-difluoro-1H-indole-2-carboxylate
CAS.NO:220679-10-7
Synonyms:Ethyl 5,7-difluoro-1H-indole-2-carboxylate
5,7-Difluoroindole-2-carboxylic acid ethyl ester
Ethyl 5,7-difluoroindole-2-carboxylate
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 342.5±37.0 °C at 760 mmHg
Molecular Formula C11H9F2NO2
Molecular Weight 225.191
Flash Point 160.9±26.5 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.581
 
Specification:
Appearance:White powder
Assay:≥97.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

Ethyl 5,7-difluoro-1H-indole-2-carboxylate


Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).35654-56-9 According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).bencilo N – [(1Z) -1-amino-1-hidroxiimino-2-metilpropan-2-il] carbamato CAS:518047-98-8 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.4-(Trifluoromethoxy)benzonitrile CAS:332-25-2 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
5-Amino-2-methylbenzenesulfonamide View Details
1-methylsulfanylpropan-2-one View Details
2-bromophenanthrene-9,10-dione View Details
3-(Difluoromethoxy)nitrobenzene manufacturer Diethyl [(2-chloroethoxy)methyl]phosphonate manufacturer 4-Methyl-3-nitropyridine manufacturer Ethylbutylamine manufacturer 4-Hydroxypyridine-3-sulfonic acid manufacturer